CERT1 and type 2 diabetes mellitus: Under T2DM glucolipotoxicity, the total amount of CERT decreased, and CERT activity is very low, hindering ceramide transport from the ER to the Golgi and reducing ceramide utilization rates, promoting ceramide accumulation in the ER (Gjoni et al., 2014).